Stock·NASDAQ·Technology
MongoDB Inc (MDB)
- Market cap
- $31.35B
- P/E
- 540.43
- Dividend yield
- None
- Street target
- $462.50median of 40 analysts
- 52-week range
- $215.68 $473.10
MDB stock forecast today
Where MDB stands today, and what CleaRank Financial AI makes of it.
MDB at a glance
MongoDB Inc (MDB): Buy, 60/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($387.09 and $338.22).
- Insiders Insiders sold $163.6M and made no open-market purchases over the last 18 months.
- Valuation P/E of 540.4 against 35.1 for the Technology sector: a premium to peers (+1,440%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates MongoDB Inc (MDB) Buy, with a model score of 60/100.
The analysts' outlook lifts the score most: 32 of 40 analysts rate it a buy and the median target is 18.9% above the price. Valuation holds it back most: the P/E of 540.43 is 1,439.7% above the sector median (a premium to peers) and the P/S of 10.74 is 41.3% above the sector median. The trend is up: MDB trades 0.52% above its 50-day average of $387.09 and 15.05% above its 200-day average of $338.22. Over the past year the price rose 16.65%.
Only on CleaRank
Figures we compute ourselves from MDB's own price, earnings and insider-filing history. Tap one to see it in context.
MDB stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $389.11 is 0.5% above the 50-day simple moving average of $387.09.Price above its 200-day average ›
The price is 15.0% above the 200-day simple moving average of $338.22.50-day average above the 200-day ›
The 50-day average ($387.09) is 14.4% above the 200-day average ($338.22), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 67% of its 52-week range, between $215.68 and $473.10.
MDB share price
Pick a period: each tab shows how far MDB has moved over it, to the last close.
Today's trading
Where MDB sits inside today's range and its 52-week range.
MDB fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/E below the sector median ›
The trailing P/E of 540.43 is 1,439.7% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 11.26 is 48.2% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $58.9M on revenue of $2.8B, a net margin of 2.1%.
Key statistics
The headline figures for MDB.
As of October 26, 2026, MDB trades at $389.11, with a market value of $31.35B and a P/E ratio of 540.43.
What the numbers say
CleaRank Financial AI's reading of MDB's valuation, growth and risks.
At 515.40 times trailing earnings, MDB trades 1,368.4% above the Technology sector median P/E of 35.1, and the peer comparison on this page calls that a premium to peers. On sales, its P/S of 11.26 is 48.2% above the sector median of 7.6. To put the earnings side in scale, trailing earnings come to $0.72 per share.
Profitability shows a net margin of 2.12% and an operating margin of 3.68%. It generates a return on equity of 1.99%, below the sector median of 13.4%. It also reports debt-to-equity of 0.02.
MDB's daily returns have a 30-day standard deviation of 5.04%, and its beta against the S&P 500 is 1.75. The valuation narrows the room for error: with a P/E of 540.43, the stock is 1,439.7% above the sector median, a premium to peers. Likewise, the price is 17.75% below the 52-week high of $473.10. Insiders sold $163.6M of stock over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover taxes on vesting shares, so they carry less weight than open-market buying.
MDB against the Technology sector
How MDB compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: MDB trades at a significant premium to sector peers (+1,440%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 14, 2025, MDB has gained 100.8% against a gain of 59.2% for XLK.
Performance against XLK
MDB and the Technology sector fund over the same days.
Revenue and earnings
How much MDB sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to April 30, 2026); MDB reported again on September 1, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 22.8% in FY2026 to $2.5B, from $2.0B a year earlier.
Profit margin: The net margin was -2.9% in FY2026, up from -6.4% the year before.
Loss-making: MDB lost $71.2M in FY2026.
MDB AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 54.3, in neutral territory.RSI above 50 ›
An RSI of 54.3 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of MDB
The score, the reasoning behind it, and what could move the price next.
MDB is in an uptrend on the averages: the price of $389.11 sits 0.52% above its 50-day average of $387.09 and 15.05% above its 200-day average of $338.22. The 50-day average is 14.45% above the 200-day, which means the shorter trend is pulling ahead of the longer one. Within its 52-week range, running from $215.68 up to $473.10, the price stands at 67%.
The stock's recent pullback sits within a stronger longer-term picture. Over the past month the price slipped 5.20%, but it climbed 25.64% over three months and 16.65% over the past year. In the last session the price gained 4.86% while trading volume ran 41.6% below its average. Momentum is mixed: the 14-day RSI sits at 54.3, which is neutral territory, and the MACD line is negative.
Rating reaffirmed ›
Needham kept its Buy rating on October 13, 2026.
Source: Analyst action, Needham, October 13, 2026
- Keep an eye on the two closest levels: the 52-week high at $473.10 overhead and the 50-day SMA at $387.09 underneath.
- The 14-day RSI is 54.3, which is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
MDB trades above its 50-day and 200-day moving averages ($387.09 and $338.22), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 50-day SMA at $387.09.
The next level above the price is the 52-week high of $473.10. The 14-day RSI of 54.3 keeps momentum in the neutral band of 40 to 60.
Technical indicators
Momentum and trend for MDB, from its daily closes.
As of October 26, 2026, with MDB at $389.11, its 14-day RSI is 54.3 (neutral territory), its 50-day simple moving average is $387.09 and its 200-day is $338.22.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What MDB moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, MDB's 1-year correlation of daily returns is +0.41 with S&P 500 (SPY), +0.42 with Nasdaq 100 (QQQ), +0.22 with Bitcoin (BTC) and +0.10 with gold (XAU).
MDB price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
32 of 40 analysts rate it a buy or strong buy, 8 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $462.50 is 18.9% above the price.More buy ratings than three months ago ›
32 of 40 rate it a buy now, against 31 of 40 three months ago.
MDB Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 13, 2026 | Needham | Reiterates | Buy |
| Oct 8, 2026 | Scotiabank | Maintains | Sector Outperform |
| Oct 2, 2026 | Cantor Fitzgerald | Reiterates | Overweight |
| Oct 1, 2026 | DA Davidson | Maintains | Buy |
| Sep 30, 2026 | DA Davidson | Maintains | Buy |
| Sep 30, 2026 | UBS | Maintains | Neutral |
As of October 26, 2026, 40 Wall Street analysts cover MDB: 32 rate it a buy or strong buy, 8 a hold and 0 a sell or strong sell. Their 12-month price targets range from $335.00 to $565.00. The median MDB price target is $462.50, 18.9% above the price of $389.11.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
MDB trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
MDB trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
MDB moves about 5.0% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much MDB tends to move, against the market and on its own.
MDB price history and drawdowns
MDB's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 5.04% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 74.9%, from November 2021 to November 2022; the price is still 31.9% below that peak.Most 1-year holds ended higher ›
69% of 1-year holding periods in the last 9 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2017 is now worth $121,331, against $34,324 in the S&P 500 (SPY).
MDB Drawdowns & Recovery
As of October 26, 2026, MDB's worst peak-to-trough fall over the last 9 years with dividends reinvested was -74.9% (November 2021 to November 2022); it is still 31.9% below that peak, and 69% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into MDB in October 2017 is worth now, against the same amount in the S&P 500.
Against the market: MDB beat the S&P 500 over this period: $121,331 against $34,324.
A $10,000 investment in MDB in October 2017 would be worth about $121,331 today with dividends reinvested, compared with about $34,324 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to MDB, and which have not.
Strongest month, August: an average of +15.30%, up in 7 of 9 years.
Weakest month, September: an average of -5.45%, up in 4 of 9 years.
This month, October: has averaged +1.80%, up in 4 of 8 years. Past seasonality does not repeat on schedule.
Over the last 9 years, MDB's strongest calendar month has been August (average +15.30%, up in 7 of 9 years) and its weakest September (average -5.45%, up in 4 of 9 years).
Average return for each calendar month over the last 9 years, from weekly closing prices with dividends included.
MDB stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in MDB, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 9 years of price history, projects that a $10,000 investment in MDB today could grow to about $15,422 by 2030 in the base case, with a 90th-percentile outcome near $55,557 and a 10th-percentile outcome around $4,281. Projections are statistical simulations, not guarantees.
MDB Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $600 for MDB by 2030 in the base case, from $389 today (1.5x over 4 years). The 10th-percentile path ends near $167. These are outcomes of a Monte Carlo simulation run on MDB's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $228 | $434 | $823 | |
| 2028 | $195 | $483 | $1,196 | |
| 2029 | $177 | $538 | $1,634 | |
| 2030 | $167 | $600 | $2,162 |
Method: a lognormal simulation of MDB's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. MDB is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
MDB insider trading
What the people running the company have bought and sold.
MDB insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought MDB shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, MDB insiders reported 54 open-market sales worth $163.6M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Archana Agrawal
Director
|
Sell | 1.0K | $400.0K |
| Oct 9, 2026 | Dwight A Merriman
Director
|
Sell | 14.0K | $5.1M |
| Oct 6, 2026 | Charles M. Hazard Jr.
Director
|
Sell | 595 | $216.5K |
| Sep 17, 2026 | Hope F Cochran
Director
|
Sell | 1.0K | $375.9K |
| Aug 17, 2026 | Dwight A Merriman
Director
|
Sell | 16.0K | $7.4M |
| Jul 16, 2026 | Dwight A Merriman
Director
|
Sell | 16.0K | $5.2M |
| Jul 8, 2026 | Michael J Berry
Chief Financial Officer
|
Grant | 10.9K | - |
| Jul 1, 2026 | Hope F Cochran
Director
|
Sell | 1.0K | $350.0K |
| Jun 30, 2026 | Dwight A Merriman
Director
|
Sell | 1.1K | $377.7K |
| Jun 30, 2026 | Archana Agrawal
Director
|
Grant | 767 | - |
| Jun 30, 2026 | Roelof Frederick Botha
Director
|
Grant | 917 | - |
| Jun 30, 2026 | Hope F Cochran
Director
|
Grant | 966 | - |
| Jun 30, 2026 | Souza Francisco D
Director
|
Grant | 951 | - |
| Jun 30, 2026 | Charles M. Hazard Jr.
Director
|
Grant | 965 | - |
| Jun 30, 2026 | Peter Thomas Killalea
Director
|
Grant | 767 | - |
| Jun 30, 2026 | Ann Lewnes
Director
|
Grant | 926 | - |
| Jun 30, 2026 | Dwight A Merriman
Director
|
Grant | 767 | - |
| Jun 17, 2026 | Hope F Cochran
Director
|
Sell | 1.6K | $538.8K |
| Jun 17, 2026 | Hope F Cochran
Director
|
Option | 3.9K | $29.7K |
| Jun 16, 2026 | Michael J Berry
Chief Financial Officer
|
Sell | 5.0K | $1.8M |
| Jun 15, 2026 | Dwight A Merriman
Director
|
Sell | 16.0K | $5.6M |
| Jun 15, 2026 | Michael J Berry
Chief Financial Officer
|
Sell | 5.0K | $1.8M |
| Jun 4, 2026 | Dev C Ittycheria
Director
|
Sell | 40.0K | $15.3M |
| Jun 2, 2026 | Roelof Frederick Botha
Director
|
Sell | 44.1K | $17.5M |
| May 29, 2026 | Hope F Cochran
Director
|
Sell | 1.0K | $350.0K |
| May 18, 2026 | Dwight A Merriman
Director
|
Sell | 16.0K | $4.9M |
| May 7, 2026 | Dwight A Merriman
Director
|
Sell | 2.0K | $580.1K |
| Apr 16, 2026 | Dwight A Merriman
Director
|
Sell | 12.0K | $2.9M |
| Apr 1, 2026 | Hope F Cochran
Director
|
Sell | 1.6K | $390.5K |
| Apr 1, 2026 | Hope F Cochran
Director
|
Option | 3.9K | $29.7K |
| Apr 1, 2026 | Dev C Ittycheria
Director
|
Grant | 44.6K | - |
| Apr 1, 2026 | Cedric Pech
Officer
|
Grant | 21.9K | - |
| Mar 17, 2026 | Michael J Berry
Chief Financial Officer
|
Grant | 17.0K | - |
| Mar 17, 2026 | Chirantan Jitendra Desai
Chief Executive Officer
|
Grant | 34.8K | - |
| Mar 16, 2026 | Dwight A Merriman
Director
|
Sell | 12.0K | $3.1M |
| Feb 17, 2026 | Dwight A Merriman
Director
|
Sell | 17.2K | $6.2M |
| Feb 2, 2026 | Dwight A Merriman
Director
|
Sell | 1.2K | $440.0K |
| Jan 15, 2026 | Dwight A Merriman
Director
|
Sell | 17.1K | $7.0M |
| Jan 2, 2026 | Dwight A Merriman
Director
|
Sell | 1.1K | $445.3K |
| Dec 29, 2025 | Dev C Ittycheria
Director
|
Grant | 13.0K | - |
| Dec 17, 2025 | Hope F Cochran
Director
|
Sell | 2.6K | $1.1M |
| Dec 17, 2025 | Hope F Cochran
Director
|
Option | 3.9K | $29.7K |
| Dec 15, 2025 | Dwight A Merriman
Director
|
Sell | 16.0K | $6.7M |
| Dec 8, 2025 | Thomas Bull
Officer
|
Sell | 555 | $229.7K |
| Dec 5, 2025 | Roelof Frederick Botha
Director
|
Sell | 24.9K | $10.1M |
| Dec 2, 2025 | Dwight A Merriman
Director
|
Sell | 4.0K | $1.6M |
| Dec 1, 2025 | Charles M. Hazard Jr.
Director
|
Sell | 999 | $325.8K |
| Nov 14, 2025 | Dwight A Merriman
Director
|
Sell | 10.0K | $3.4M |
| Nov 12, 2025 | Dwight A Merriman
Director
|
Sell | 6.0K | $2.2M |
| Nov 10, 2025 | Chirantan Jitendra Desai
Chief Executive Officer
|
Grant | 44.1K | - |
| Nov 3, 2025 | Charles M. Hazard Jr.
Director
|
Sell | 999 | $383.3K |
| Oct 27, 2025 | Dwight A Merriman
Director
|
Sell | 4.0K | $1.4M |
| Oct 16, 2025 | Dwight A Merriman
Director
|
Sell | 16.0K | $5.0M |
| Oct 1, 2025 | Charles M. Hazard Jr.
Director
|
Sell | 999 | $311.6K |
| Oct 1, 2025 | Dev C Ittycheria
Chief Executive Officer
|
Grant | 892 | - |
| Sep 23, 2025 | Peter Thomas Killalea
Director
|
Sell | 20.0K | $6.4M |
| Sep 23, 2025 | Peter Thomas Killalea
Director
|
Option | 20.0K | $130.0K |
| Sep 19, 2025 | Dwight A Merriman
Director
|
Sell | 31.0K | $9.9M |
| Sep 17, 2025 | Hope F Cochran
Director
|
Sell | 1.2K | $385.0K |
| Sep 17, 2025 | Hope F Cochran
Director
|
Option | 2.9K | $22.3K |
| Sep 8, 2025 | Thomas Bull
Officer
|
Sell | 1.0K | $326.3K |
| Sep 2, 2025 | Charles M. Hazard Jr.
Director
|
Sell | 999 | $309.7K |
| Aug 28, 2025 | Dev C Ittycheria
Chief Executive Officer
|
Sell | 33.3K | $10.0M |
| Aug 28, 2025 | Charles M. Hazard Jr.
Director
|
Sell | 8.0K | $2.4M |
| Jul 31, 2025 | Thomas Bull
Officer
|
Sell | 2.0K | $500.0K |
| Jul 28, 2025 | Dev C Ittycheria
Chief Executive Officer
|
Sell | 16.7K | $4.0M |
| Jul 25, 2025 | Dwight A Merriman
Director
|
Sell | 1.0K | $245.0K |
| Jul 22, 2025 | Dwight A Merriman
Director
|
Sell | 1.0K | $225.0K |
| Jul 2, 2025 | Dev C Ittycheria
Chief Executive Officer
|
Sell | 3.7K | $772.1K |
| Jul 2, 2025 | Dwight A Merriman
Director
|
Sell | 1.0K | $206.1K |
| Jul 2, 2025 | Cedric Pech
Officer
|
Sell | 354 | $72.9K |
| Jun 30, 2025 | Archana Agrawal
Director
|
Grant | 1.4K | - |
| Jun 30, 2025 | Roelof Frederick Botha
Director
|
Grant | 1.4K | - |
| Jun 30, 2025 | Hope F Cochran
Director
|
Grant | 1.4K | - |
| Jun 30, 2025 | Souza Francisco D
Director
|
Grant | 1.4K | - |
| Jun 30, 2025 | Charles M. Hazard Jr.
Director
|
Grant | 1.4K | - |
| Jun 30, 2025 | Peter Thomas Killalea
Director
|
Grant | 1.1K | - |
| Jun 30, 2025 | Ann Lewnes
Director
|
Grant | 1.4K | - |
| Jun 30, 2025 | Dwight A Merriman
Director
|
Grant | 1.1K | - |
| Jun 25, 2025 | Dwight A Merriman
Director
|
Sell | 820 | $172.9K |
| Jun 17, 2025 | Hope F Cochran
Director
|
Sell | 1.2K | $236.1K |
| Jun 17, 2025 | Hope F Cochran
Director
|
Option | 2.9K | $22.3K |
| Jun 5, 2025 | Dev C Ittycheria
Chief Executive Officer
|
Sell | 25.0K | $5.9M |
| Jun 5, 2025 | Dwight A Merriman
Director
|
Sell | 2.0K | $468.0K |
| Jun 5, 2025 | Dev C Ittycheria
Chief Executive Officer
|
Option | 13.0K | $84.7K |
| May 27, 2025 | Michael J Berry
Chief Financial Officer
|
Grant | 67.7K | - |
Source: TwelveData, from SEC Form 4 filings
MDB stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.